BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Aardvark Therapeutics\, Inc. (AARD) investor events
X-WR-CALNAME:Aardvark Therapeutics\, Inc. (AARD) investor events
DESCRIPTION:Earnings calls and investor events for Aardvark Therapeutics\, 
 Inc. (AARD)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Aardvark Therapeutics\,
  Inc. (AARD)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:87fea216-c5bc-4b77-90fd-e62a20bc9584@equibles.com
DTSTAMP:20260617T191124Z
DTSTART;VALUE=DATE:20251113
DTEND;VALUE=DATE:20251114
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Aardvark Therapeutics\, Inc. (AARD) Earnings Call\, FY2025 Q3
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:23e198e1-be74-486e-9b7e-23f4f4284bda@equibles.com
DTSTAMP:20260624T233118Z
DTSTART;VALUE=DATE:20251204
DTEND;VALUE=DATE:20251205
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Aardvark Therapeutics\, Inc. (AARD) Conference: Evercore ISI 8th An
 nual Healthcare Conference
DESCRIPTION:Evercore ISI 8th Annual Healthcare Conference\nThe start time h
 as not been announced.\nWebcast: https://wsw.com/webcast/evercore52/regist
 er.aspx?conf=evercore52&page=aard&url=https://wsw.com/webcast/evercore52/a
 ard/2322672
END:VEVENT
BEGIN:VEVENT
UID:d91f3256-379d-4947-ac1d-8d034a5c828e@equibles.com
DTSTAMP:20260617T191107Z
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260324
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Aardvark Therapeutics\, Inc. (AARD) Earnings Call\, FY2025 Q4
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:9d4de227-d844-4e91-824e-244446dd9a15@equibles.com
DTSTAMP:20260617T191104Z
DTSTART;VALUE=DATE:20260507
DTEND;VALUE=DATE:20260508
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Aardvark Therapeutics\, Inc. (AARD) Earnings Call\, FY2026 Q1
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
END:VCALENDAR
